Indofarma Tbk. vs Super Bank Indonesia Tbk. — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Super Bank Indonesia Tbk. trades at Rp505 (market cap 17.11T, 11.9M 24h volume). The key difference: Super Bank Indonesia Tbk. is far larger — about 43.8× Indofarma Tbk.'s market cap. Which is the better fit depends on your goals.
| INAF | SUPA | |
|---|---|---|
Market Cap | 390.51B | 17.11T |
Volume | — | 11.9M |
Lot | — | 119.04K |
Turnover | — | 6B |
Average Price | — | 504.24 |
Value | — | 6B |
Indicative Equilibrium Price | — | 505 |
Indicative Equilibrium Volume | — | 1.29K |
Trailing returns across standard periods
Latest headlines on both assets
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Read more on INAF →PT Super Bank Indonesia Tbk. (hereinafter referred to as the Bank) formerly under the name of PT Bank Fama International was established by Deed No. 36 on 5 March 1993, before Notary Herlien, S.H. The Bank has received a license as a commercial bank according to the Decree of the Minister of Finance of the Republic of Indonesia No. 834/KMK.017/1993 dated 11 October 1993.
Read more on SUPA →